Paul Tudor Jones Bio Techne Corp Call Options Transaction History

Tudor Investment Corp Et Al

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $176,925 - $243,895	-500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $319,305 - $367,541	-700 Reduced 58.33%	500 $259,000
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $622,818 - $754,432	-1,400 Reduced 53.85%	1,200 $580,000
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $1.01 Million - $1.17 Million	2,600 New	2,600 $1.17 Million

604

152M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.95B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.